CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Bobbi Fleiss - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Bobbi Fleiss

OPENALEX: A5050078207↗ORCID: 0000-0001-7828-673X↗

Affiliations

Organizations

RMIT Universityauthorship · AU

Public evidence

3 connected articles

Evaluation of the efficacy of a full-spectrum medicinal cannabis plant extract with less than 0.3% Δ9-tetrahydrocannabinol in <i>in vitro</i> models of inflammation and excitotoxicity2024 · bioRxiv Safety and efficacy of orally administered full-spectrum medicinal cannabis plant extract 0.08% THC (NTI-164) in children with autism spectrum disorder: An open-label study.2023 · medRxiv Evaluation of the Efficacy of a Full-Spectrum Low-THC <i>Cannabis</i> Plant Extract Using In Vitro Models of Inflammation and Excitotoxicity.2024 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.